11:06 AM EDT, 04/25/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by consumer goods company Unilever ( UL ) and pharmaceutical company Sanofi ( SNY ) , which rose 5.5% and 5.4% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and medical device maker EDAP TMS ( EDAP ) , which increased 0.4% and 4.7% respectively.

The decliners from continental Europe were led by biotech firm Biophytis ( BPTS ) and internet browser company Opera (OPRA), which fell 6.4% and 5.9% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and biopharmaceutical company Calliditas Therapeutics ( CALT ) , which dropped 3.1% and 3.3% respectively.

From the UK and Ireland, the gainers were led by financial services company Barclays ( JJCTF ) and biopharmaceutical company TC Biopharm ( TCBP ) , which rose 8% and 7.5% respectively. They were followed by pharmaceutical company AstraZeneca ( AZN ) and biotech firm Trinity Biotech ( TRIB ) , which were up 6% and 4.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Biodexa Pharmaceuticals ( BDRX ) , which lost 2.1% and 6.8% respectively. They were followed by pharmaceutical company Avadel Pharmaceuticals ( AVDL ) and biotech firm Autolus Therapeutics ( AUTL ) , which were down 2.5% and 3.2% respectively.